RTG 2338 Targets in Toxicology
print


Breadcrumb Navigation


Content

GRK 2338 Seminar - Thomas Singer

Global Head of Pharmaceutical Sciences, Senior Vice President Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Switzerland

27.05.2019 at 15:00 

Title: Drug Development and Modern Safety Assessment

Prof. Dr. Thomas Singer visited the GRK 2338 RTG and gave a talk about the new drug developments at Roche. Afterwards, the students had the opportunity to speak to him personally during a meet-the-speaker session.

IMG_2578

Thomas Singer Website:

https://ch.linkedin.com/in/thomas-singer-prof-phd-dabt-07536045

https://de.wikipedia.org/wiki/Thomas_Singer_(Tiermediziner)

Time:

  • 3.00 pm GRK 2338 Lecture
  • 4.00 pm Meet the Speaker Session 

Venue:

Pettenkoferstr. 12, D 030

Host: Thomas Gudermann (P10)

PhD-Host: Jonas Tigges (P02)